APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osteoporosis Injections

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Osteoporosis Injections Industry Growth and Trends Forecast to 2032

27 December 2025109 pages

Choose your research edition.

Industry ResearchOsteoporosis Injections Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Osteoporosis Injections Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Osteoporosis Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osteoporosis Injections Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Osteoporosis Injections Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Osteoporosis Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Osteoporosis Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Osteoporosis Injections is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osteoporosis Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osteoporosis Injections include Alvogen, Amgen, Asahi Kasei Pharma, Eli Lilly, Novartis, Pfizer, Pharmanovia, Radius Health and Chengdu Easton Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Osteoporosis Injections market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Osteoporosis Injections market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Osteoporosis Injections market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Osteoporosis Injections.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Osteoporosis Injections market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Osteoporosis Injections Market by Company

Alvogen

Amgen

Asahi Kasei Pharma

Eli Lilly

Novartis

Pfizer

Pharmanovia

Radius Health

Chengdu Easton Biopharmaceuticals

Hunan Fangsheng Pharmaceutical

Qilu Pharmaceutical

Shanghai United Cell Biotechnology

Shenzhen Salubris Pharmaceuticals

Osteoporosis Injections Segment by Type

Bone Formation Promoters

Bone Resorption Inhibitors

Osteoporosis Injections Segment by Application

Female

Male

Osteoporosis Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osteoporosis Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osteoporosis Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osteoporosis Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osteoporosis Injections manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Osteoporosis Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bone Formation Promoters Table 2. Major Company of Bone Resorption Inhibitors Table 3. Global Osteoporosis Injections Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 5. Global Osteoporosis Injections Sales Market Share in Volume by Type (2021-2026) Table 6. Global Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 7. Global Osteoporosis Injections Sales Market Share in Value by Type (2021-2026) Table 8. Global Osteoporosis Injections Price by Type (2021-2026) & (US$/Unit) Table 9. Global Osteoporosis Injections Sales by Type (2027-2032) & (K Units) Table 10. Global Osteoporosis Injections Sales Market Share in Volume by Type (2027-2032) Table 11. Global Osteoporosis Injections Sales by Type (2027-2032) & (US$ Million) Table 12. Global Osteoporosis Injections Sales Market Share in Value by Type (2027-2032) Table 13. Global Osteoporosis Injections Price by Type (2027-2032) & (US$/Unit) Table 14. North America Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 15. North America Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 17. Europe Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 21. Latin America Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Osteoporosis Injections Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Osteoporosis Injections Sales by Type (2021-2026) & (US$ Million) Table 24. Osteoporosis Injections Industry Trends Table 25. Osteoporosis Injections Industry Drivers Table 26. Osteoporosis Injections Industry Opportunities and Challenges Table 27. Osteoporosis Injections Industry Restraints Table 28. Global Osteoporosis Injections Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Osteoporosis Injections Revenue Market Share by Company (2021-2026) Table 30. Global Osteoporosis Injections Sales by Company (2021-2026) & (K Units) Table 31. Global Osteoporosis Injections Sales Share by Company (2021-2026) Table 32. Global Osteoporosis Injections Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Osteoporosis Injections Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Osteoporosis Injections Major Company Production Sites and Headquarters Table 35. Global Osteoporosis Injections Company, Product Type & Application Table 36. Global Osteoporosis Injections Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Osteoporosis Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Osteoporosis Injections Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Osteoporosis Injections Sales by Region (2021-2026) & (K Units) Table 41. Global Osteoporosis Injections Sales Market Share in Volume by Region (2021-2026) Table 42. Global Osteoporosis Injections Sales by Region (2021-2026) & (US$ Million) Table 43. Global Osteoporosis Injections Sales Market Share in Value by Region (2021-2026) Table 44. Global Osteoporosis Injections Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Osteoporosis Injections Sales by Region (2027-2032) & (K Units) Table 46. Global Osteoporosis Injections Sales Market Share in Volume by Region (2027-2032) Table 47. Global Osteoporosis Injections Sales by Region (2027-2032) & (US$ Million) Table 48. Global Osteoporosis Injections Sales Market Share in Value by Region (2027-2032) Table 49. Global Osteoporosis Injections Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Osteoporosis Injections Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 52. Global Osteoporosis Injections Sales Market Share in Volume by Application (2021-2026) Table 53. Global Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 54. Global Osteoporosis Injections Sales Market Share in Value by Application (2021-2026) Table 55. Global Osteoporosis Injections Price by Application (2021-2026) & (US$/Unit) Table 56. Global Osteoporosis Injections Sales by Application (2027-2032) & (K Units) Table 57. Global Osteoporosis Injections Sales Market Share in Volume by Application (2027-2032) Table 58. Global Osteoporosis Injections Sales by Application (2027-2032) & (US$ Million) Table 59. Global Osteoporosis Injections Sales Market Share in Value by Application (2027-2032) Table 60. Global Osteoporosis Injections Price by Application (2027-2032) & (US$/Unit) Table 61. North America Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 62. North America Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 64. Europe Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 68. Latin America Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Osteoporosis Injections Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Osteoporosis Injections Sales by Application (2021-2026) & (US$ Million) Table 71. Alvogen Company Information Table 72. Alvogen Business Overview Table 73. Alvogen Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alvogen Osteoporosis Injections Product Portfolio Table 75. Alvogen Recent Development Table 76. Amgen Company Information Table 77. Amgen Business Overview Table 78. Amgen Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amgen Osteoporosis Injections Product Portfolio Table 80. Amgen Recent Development Table 81. Asahi Kasei Pharma Company Information Table 82. Asahi Kasei Pharma Business Overview Table 83. Asahi Kasei Pharma Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Asahi Kasei Pharma Osteoporosis Injections Product Portfolio Table 85. Asahi Kasei Pharma Recent Development Table 86. Eli Lilly Company Information Table 87. Eli Lilly Business Overview Table 88. Eli Lilly Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eli Lilly Osteoporosis Injections Product Portfolio Table 90. Eli Lilly Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novartis Osteoporosis Injections Product Portfolio Table 95. Novartis Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Osteoporosis Injections Product Portfolio Table 100. Pfizer Recent Development Table 101. Pharmanovia Company Information Table 102. Pharmanovia Business Overview Table 103. Pharmanovia Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pharmanovia Osteoporosis Injections Product Portfolio Table 105. Pharmanovia Recent Development Table 106. Radius Health Company Information Table 107. Radius Health Business Overview Table 108. Radius Health Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Radius Health Osteoporosis Injections Product Portfolio Table 110. Radius Health Recent Development Table 111. Chengdu Easton Biopharmaceuticals Company Information Table 112. Chengdu Easton Biopharmaceuticals Business Overview Table 113. Chengdu Easton Biopharmaceuticals Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Chengdu Easton Biopharmaceuticals Osteoporosis Injections Product Portfolio Table 115. Chengdu Easton Biopharmaceuticals Recent Development Table 116. Hunan Fangsheng Pharmaceutical Company Information Table 117. Hunan Fangsheng Pharmaceutical Business Overview Table 118. Hunan Fangsheng Pharmaceutical Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hunan Fangsheng Pharmaceutical Osteoporosis Injections Product Portfolio Table 120. Hunan Fangsheng Pharmaceutical Recent Development Table 121. Qilu Pharmaceutical Company Information Table 122. Qilu Pharmaceutical Business Overview Table 123. Qilu Pharmaceutical Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Qilu Pharmaceutical Osteoporosis Injections Product Portfolio Table 125. Qilu Pharmaceutical Recent Development Table 126. Shanghai United Cell Biotechnology Company Information Table 127. Shanghai United Cell Biotechnology Business Overview Table 128. Shanghai United Cell Biotechnology Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shanghai United Cell Biotechnology Osteoporosis Injections Product Portfolio Table 130. Shanghai United Cell Biotechnology Recent Development Table 131. Shenzhen Salubris Pharmaceuticals Company Information Table 132. Shenzhen Salubris Pharmaceuticals Business Overview Table 133. Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Product Portfolio Table 135. Shenzhen Salubris Pharmaceuticals Recent Development Table 136. North America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Osteoporosis Injections Sales by Country (2021-2026) & (K Units) Table 138. North America Osteoporosis Injections Sales Market Share by Country (2021-2026) Table 139. North America Osteoporosis Injections Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Osteoporosis Injections Sales Market Share Forecast by Country (2027-2032) Table 141. North America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Osteoporosis Injections Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Osteoporosis Injections Market Share by Country (2021-2026) Table 144. North America Osteoporosis Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Osteoporosis Injections Market Share Forecast by Country (2027-2032) Table 146. Europe Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Osteoporosis Injections Sales by Country (2021-2026) & (K Units) Table 148. Europe Osteoporosis Injections Sales Market Share by Country (2021-2026) Table 149. Europe Osteoporosis Injections Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Osteoporosis Injections Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Osteoporosis Injections Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Osteoporosis Injections Market Share by Country (2021-2026) Table 154. Europe Osteoporosis Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Osteoporosis Injections Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Osteoporosis Injections Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Osteoporosis Injections Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Osteoporosis Injections Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Osteoporosis Injections Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Osteoporosis Injections Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Osteoporosis Injections Market Share by Country (2021-2026) Table 164. Asia-Pacific Osteoporosis Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Osteoporosis Injections Market Share Forecast by Country (2027-2032) Table 166. Latin America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Osteoporosis Injections Sales by Country (2021-2026) & (K Units) Table 168. Latin America Osteoporosis Injections Sales Market Share by Country (2021-2026) Table 169. Latin America Osteoporosis Injections Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Osteoporosis Injections Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Osteoporosis Injections Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Osteoporosis Injections Market Share by Country (2021-2026) Table 174. Latin America Osteoporosis Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Osteoporosis Injections Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Osteoporosis Injections Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Osteoporosis Injections Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Osteoporosis Injections Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Osteoporosis Injections Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Osteoporosis Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Osteoporosis Injections Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Osteoporosis Injections Market Share by Country (2021-2026) Table 184. Middle East and Africa Osteoporosis Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Osteoporosis Injections Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Osteoporosis Injections Distributors List Table 189. Osteoporosis Injections Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Osteoporosis Injections Image Figure 2. Global Osteoporosis Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osteoporosis Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global Osteoporosis Injections Sales (2021-2032) & (K Units) Figure 5. Bone Formation Promoters Image Figure 6. Global Bone Formation Promoters Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bone Resorption Inhibitors Image Figure 8. Global Bone Resorption Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Osteoporosis Injections Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Osteoporosis Injections Market Share by Type 2025 VS 2032 Figure 11. North America Osteoporosis Injections Sales Market Share in Volume by Type in 2025 Figure 12. North America Osteoporosis Injections Sales Market Share in Value by Type in 2025 Figure 13. Europe Osteoporosis Injections Sales Market Share in Volume by Type in 2025 Figure 14. Europe Osteoporosis Injections Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Osteoporosis Injections Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Osteoporosis Injections Sales Market Share in Value by Type in 2025 Figure 17. Latin America Osteoporosis Injections Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Osteoporosis Injections Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Osteoporosis Injections Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Osteoporosis Injections Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Osteoporosis Injections Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Female Image Figure 24. Global Female Sales YoY Growth (2021-2032) & (K Units) Figure 25. Male Image Figure 26. Global Male Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Osteoporosis Injections Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Osteoporosis Injections Market Share by Application 2025 VS 2032 Figure 29. North America Osteoporosis Injections Sales Market Share in Volume by Application in 2025 Figure 30. North America Osteoporosis Injections Sales Market Share in Value by Application in 2025 Figure 31. Europe Osteoporosis Injections Sales Market Share in Volume by Application in 2025 Figure 32. Europe Osteoporosis Injections Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Osteoporosis Injections Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Osteoporosis Injections Sales Market Share in Value by Application in 2025 Figure 35. Latin America Osteoporosis Injections Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Osteoporosis Injections Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Osteoporosis Injections Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Osteoporosis Injections Sales Market Share in Value by Application in 2025 Figure 39. North America Osteoporosis Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Osteoporosis Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Osteoporosis Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Osteoporosis Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Osteoporosis Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Osteoporosis Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Osteoporosis Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Osteoporosis Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Osteoporosis Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Osteoporosis Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Osteoporosis Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Osteoporosis Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Osteoporosis Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Osteoporosis Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Osteoporosis Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Osteoporosis Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Osteoporosis Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Osteoporosis Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Osteoporosis Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Osteoporosis Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Osteoporosis Injections Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Osteoporosis Injections Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Formation Promoters
  • Bone Resorption Inhibitors
Applications
  • Female
  • Male
Companies covered
  • Alvogen
  • Amgen
  • Asahi Kasei Pharma
  • Eli Lilly
  • Novartis
  • Pfizer
  • Pharmanovia
  • Radius Health
  • Chengdu Easton Biopharmaceuticals
  • Hunan Fangsheng Pharmaceutical
  • Qilu Pharmaceutical
  • Shanghai United Cell Biotechnology
  • Shenzhen Salubris Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osteoporosis Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Osteoporosis Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Osteoporosis Injections Market by Type
  6. 1.3.1 Bone Formation Promoters
  7. 1.3.2 Bone Resorption Inhibitors
  8. 1.4 Global Osteoporosis Injections Market Size by Type
  9. 1.4.1 Global Osteoporosis Injections Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Osteoporosis Injections Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Osteoporosis Injections Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Osteoporosis Injections Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Osteoporosis Injections Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Osteoporosis Injections Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Osteoporosis Injections Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Osteoporosis Injections Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Osteoporosis Injections Industry Trends
  2. 2.2 Osteoporosis Injections Industry Drivers
  3. 2.3 Osteoporosis Injections Industry Opportunities and Challenges
  4. 2.4 Osteoporosis Injections Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Osteoporosis Injections Revenue (2021-2026)
  2. 3.2 Global Top Players by Osteoporosis Injections Sales (2021-2026)
  3. 3.3 Global Top Players by Osteoporosis Injections Price (2021-2026)
  4. 3.4 Global Osteoporosis Injections Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osteoporosis Injections Major Company Production Sites & Headquarters
  6. 3.6 Global Osteoporosis Injections Company, Product Type & Application
  7. 3.7 Global Osteoporosis Injections Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osteoporosis Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osteoporosis Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osteoporosis Injections Tier 1, Tier 2, and Tier 3
4 Osteoporosis Injections Regional Status and Outlook
  1. 4.1 Global Osteoporosis Injections Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Osteoporosis Injections Historic Market Size by Region
  3. 4.2.1 Global Osteoporosis Injections Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Osteoporosis Injections Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Osteoporosis Injections Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Osteoporosis Injections Forecasted Market Size by Region
  7. 4.3.1 Global Osteoporosis Injections Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Osteoporosis Injections Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Osteoporosis Injections Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Osteoporosis Injections by Application
  1. 5.1 Osteoporosis Injections Market by Application
  2. 5.1.1 Female
  3. 5.1.2 Male
  4. 5.2 Global Osteoporosis Injections Market Size by Application
  5. 5.2.1 Global Osteoporosis Injections Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Osteoporosis Injections Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Osteoporosis Injections Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Osteoporosis Injections Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Osteoporosis Injections Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Osteoporosis Injections Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Osteoporosis Injections Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Osteoporosis Injections Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alvogen
  2. 6.1.1 Alvogen Company Information
  3. 6.1.2 Alvogen Business Overview
  4. 6.1.3 Alvogen Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alvogen Osteoporosis Injections Product Portfolio
  6. 6.1.5 Alvogen Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Osteoporosis Injections Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Asahi Kasei Pharma
  14. 6.3.1 Asahi Kasei Pharma Company Information
  15. 6.3.2 Asahi Kasei Pharma Business Overview
  16. 6.3.3 Asahi Kasei Pharma Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Asahi Kasei Pharma Osteoporosis Injections Product Portfolio
  18. 6.3.5 Asahi Kasei Pharma Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Osteoporosis Injections Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Osteoporosis Injections Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Osteoporosis Injections Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Pharmanovia
  38. 6.7.1 Pharmanovia Company Information
  39. 6.7.2 Pharmanovia Business Overview
  40. 6.7.3 Pharmanovia Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pharmanovia Osteoporosis Injections Product Portfolio
  42. 6.7.5 Pharmanovia Recent Developments
  43. 6.8 Radius Health
  44. 6.8.1 Radius Health Company Information
  45. 6.8.2 Radius Health Business Overview
  46. 6.8.3 Radius Health Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Radius Health Osteoporosis Injections Product Portfolio
  48. 6.8.5 Radius Health Recent Developments
  49. 6.9 Chengdu Easton Biopharmaceuticals
  50. 6.9.1 Chengdu Easton Biopharmaceuticals Company Information
  51. 6.9.2 Chengdu Easton Biopharmaceuticals Business Overview
  52. 6.9.3 Chengdu Easton Biopharmaceuticals Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chengdu Easton Biopharmaceuticals Osteoporosis Injections Product Portfolio
  54. 6.9.5 Chengdu Easton Biopharmaceuticals Recent Developments
  55. 6.10 Hunan Fangsheng Pharmaceutical
  56. 6.10.1 Hunan Fangsheng Pharmaceutical Company Information
  57. 6.10.2 Hunan Fangsheng Pharmaceutical Business Overview
  58. 6.10.3 Hunan Fangsheng Pharmaceutical Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hunan Fangsheng Pharmaceutical Osteoporosis Injections Product Portfolio
  60. 6.10.5 Hunan Fangsheng Pharmaceutical Recent Developments
  61. 6.11 Qilu Pharmaceutical
  62. 6.11.1 Qilu Pharmaceutical Company Information
  63. 6.11.2 Qilu Pharmaceutical Business Overview
  64. 6.11.3 Qilu Pharmaceutical Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Qilu Pharmaceutical Osteoporosis Injections Product Portfolio
  66. 6.11.5 Qilu Pharmaceutical Recent Developments
  67. 6.12 Shanghai United Cell Biotechnology
  68. 6.12.1 Shanghai United Cell Biotechnology Company Information
  69. 6.12.2 Shanghai United Cell Biotechnology Business Overview
  70. 6.12.3 Shanghai United Cell Biotechnology Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai United Cell Biotechnology Osteoporosis Injections Product Portfolio
  72. 6.12.5 Shanghai United Cell Biotechnology Recent Developments
  73. 6.13 Shenzhen Salubris Pharmaceuticals
  74. 6.13.1 Shenzhen Salubris Pharmaceuticals Company Information
  75. 6.13.2 Shenzhen Salubris Pharmaceuticals Business Overview
  76. 6.13.3 Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Product Portfolio
  78. 6.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Osteoporosis Injections Sales by Country
  2. 7.1.1 North America Osteoporosis Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Osteoporosis Injections Sales by Country (2021-2026)
  4. 7.1.3 North America Osteoporosis Injections Sales Forecast by Country (2027-2032)
  5. 7.2 North America Osteoporosis Injections Market Size by Country
  6. 7.2.1 North America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Osteoporosis Injections Market Size by Country (2021-2026)
  8. 7.2.3 North America Osteoporosis Injections Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Osteoporosis Injections Sales by Country
  2. 8.1.1 Europe Osteoporosis Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Osteoporosis Injections Sales by Country (2021-2026)
  4. 8.1.3 Europe Osteoporosis Injections Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Osteoporosis Injections Market Size by Country
  6. 8.2.1 Europe Osteoporosis Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Osteoporosis Injections Market Size by Country (2021-2026)
  8. 8.2.3 Europe Osteoporosis Injections Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Osteoporosis Injections Sales by Country
  2. 9.1.1 Asia-Pacific Osteoporosis Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Osteoporosis Injections Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Osteoporosis Injections Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Osteoporosis Injections Market Size by Country
  6. 9.2.1 Asia-Pacific Osteoporosis Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Osteoporosis Injections Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Osteoporosis Injections Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Osteoporosis Injections Sales by Country
  2. 10.1.1 South America Osteoporosis Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Osteoporosis Injections Sales by Country (2021-2026)
  4. 10.1.3 South America Osteoporosis Injections Sales Forecast by Country (2027-2032)
  5. 10.2 South America Osteoporosis Injections Market Size by Country
  6. 10.2.1 South America Osteoporosis Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Osteoporosis Injections Market Size by Country (2021-2026)
  8. 10.2.3 South America Osteoporosis Injections Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Osteoporosis Injections Sales by Country
  2. 11.1.1 Middle East and Africa Osteoporosis Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Osteoporosis Injections Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Osteoporosis Injections Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Osteoporosis Injections Market Size by Country
  6. 11.2.1 Middle East and Africa Osteoporosis Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Osteoporosis Injections Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Osteoporosis Injections Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Osteoporosis Injections Value Chain Analysis
  2. 12.1.1 Osteoporosis Injections Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Osteoporosis Injections Production Mode & Process
  7. 12.2 Osteoporosis Injections Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Osteoporosis Injections Distributors
  10. 12.2.3 Osteoporosis Injections Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst